Fertility warning
This medicine may affect fertility.
Leaflet IMAKREBIN 100mg film-coated tablets
- Product code:
- W59486006
- Quantity:
- 120
- Indicated for:
- chronic myeloid leukemia; gastrointestinal stromal tumors
- Route of administration:
- oral
- Substance:
- imatinib (tyrosine kinase inhibitor)
- ATC
- L01EA01 — Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors
Precautions:
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Avoid grapefruit
Avoid grapefruit and grapefruit juice.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Cardiac risk / QT prolongation / arrhythmias
This medicine may increase the risk of heart rhythm disturbances.
Imatinib is a tyrosine kinase inhibitor used for the treatment of chronic myeloid leukemia (CML) and other cancers, such as gastrointestinal stromal tumors (GIST). It works by blocking the activity of abnormal proteins that drive cancer cell growth.
The medication is taken orally, usually once daily, as directed by a doctor. It is important to follow the recommended dose to maximize treatment effectiveness.
Side effects may include nausea, vomiting, fluid retention, muscle pain, or fatigue. In rare cases, severe allergic reactions or liver failure may occur.
Imatinib is not recommended for patients with hypersensitivity to this medication or severe liver impairment.
The medication is taken orally, usually once daily, as directed by a doctor. It is important to follow the recommended dose to maximize treatment effectiveness.
Side effects may include nausea, vomiting, fluid retention, muscle pain, or fatigue. In rare cases, severe allergic reactions or liver failure may occur.
Imatinib is not recommended for patients with hypersensitivity to this medication or severe liver impairment.
General data about IMAKREBIN 100mg
- Substance:
- imatinib
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W59486006
- Concentration:
- 100mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 120
- Product type:
- Generic medicine
- Price:
- 807.62 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for imatinib
Concentrations available for imatinib
- 100mg
- 300mg
- 400mg
- 50mg